Covaxin – THE OVAL CIRCLE

WHO greenlights India’s domestically made Covaxin Covid-19 vaccine for emergency use

Posted on November 4, 2021November 4, 2021By Editor

The World Health Organization (WHO) has approved Bharat Biotech’s Covid-19 jab, Covaxin, for emergency use after determining that the Indian vaccine meets the body’s standards for protecting against the virus. … Read More >WHO greenlights India’s domestically made Covaxin Covid-19 vaccine for emergency use

India’s indigenously developed Covaxin jab 78% effective against Covid-19 in trials, maker Bharat Biotech says

Posted on April 22, 2021April 22, 2021By Editor

The Covid-19 vaccine developed by Indian pharmaceutical firm Bharat Biotech has been found to be 78% effective in preventing symptoms of Covid-19 and 100% against severe disease in stage three trials, the company said. … Read More >India’s indigenously developed Covaxin jab 78% effective against Covid-19 in trials, maker Bharat Biotech says

Brazilian prosecutors call on govt to suspend 20 million-dose deal with India’s Covaxin jab over lack of Phase 3 trial data

Posted on February 28, 2021February 28, 2021By Editor

The Public Prosecutor’s Office in Brazil has asked the Federal Audit Court to suspend an order for 20 million doses of the Covaxin Covid-19 jab made by India’s Bharat Biotech, ahead of a vaccine factory inspection next week. … Read More >Brazilian prosecutors call on govt to suspend 20 million-dose deal with India’s Covaxin jab over lack of Phase 3 trial data